Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?
about
Imipenem for treatment of tuberculosis in mice and humansGenome-wide regulon and crystal structure of BlaI (Rv1846c) from Mycobacterium tuberculosisUnusual Conformation of the SxN Motif in the Crystal Structure of Penicillin-Binding Protein A from Mycobacterium tuberculosisStructure of the Mycobacterium tuberculosis OmpATb protein: a model of an oligomeric channel in the mycobacterial cell wallDirected evolution of Mycobacterium tuberculosis β-lactamase reveals gatekeeper residue that regulates antibiotic resistance and catalytic efficiencyCan Inhibitor-Resistant Substitutions in the Mycobacterium tuberculosis -Lactamase BlaC Lead to Clavulanate Resistance?: a Biochemical Rationale for the Use of -Lactam- -Lactamase Inhibitor CombinationsEarly bactericidal activity of amoxicillin in combination with clavulanic acid in patients with sputum smear-positive pulmonary tuberculosisCellular impermeability and uptake of biocides and antibiotics in Gram-positive bacteria and mycobacteriaContribution of beta-lactamases to beta-lactam susceptibilities of susceptible and multidrug-resistant Mycobacterium tuberculosis clinical isolatesThe peptidoglycan of stationary-phase Mycobacterium tuberculosis predominantly contains cross-links generated by L,D-transpeptidationCloning and sequence analysis of a class A beta-lactamase from Mycobacterium tuberculosis H37RaRecombinant expression and characterization of the major beta-lactamase of Mycobacterium tuberculosis.pH-dependent pore-forming activity of OmpATb from Mycobacterium tuberculosis and characterization of the channel by peptidic dissectionInactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelopeMMAS-1, the branch point between cis- and trans-cyclopropane-containing oxygenated mycolates in Mycobacterium tuberculosisIdentification of a novel multidrug efflux pump of Mycobacterium tuberculosisInactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulenceOverexpression, purification and biochemical characterization of a class A high-molecular-mass penicillin-binding protein (PBP), PBP1* and its soluble derivative from Mycobacterium tuberculosisThe functions of OmpATb, a pore-forming protein of Mycobacterium tuberculosisMorphological features and signature gene response elicited by inactivation of FtsI in Mycobacterium tuberculosisCrystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibioticsMolecular cloning, overexpression and biochemical characterization of hypothetical beta-lactamases of Mycobacterium tuberculosis H37RvAnalysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrierExpression of a gene for a porin-like protein of the OmpA family from Mycobacterium tuberculosis H37RvA Mycobacterium smegmatis mutant with a defective inositol monophosphate phosphatase gene homolog has altered cell envelope permeabilityMolecular basis of bacterial outer membrane permeability revisitedTopology of the porin MspA in the outer membrane of Mycobacterium smegmatis.Characterization of novel Mycobacterium tuberculosis and Mycobacterium smegmatis mutants hypersusceptible to beta-lactam antibiotics.Mycobacterial porins--new channel proteins in unique outer membranes.Synthetic lethality reveals mechanisms of Mycobacterium tuberculosis resistance to β-lactamsBiochemistry and comparative genomics of SxxK superfamily acyltransferases offer a clue to the mycobacterial paradox: presence of penicillin-susceptible target proteins versus lack of efficiency of penicillin as therapeutic agent.Biosynthesis of the arabinogalactan-peptidoglycan complex of Mycobacterium tuberculosis.Bacterial growth and cell division: a mycobacterial perspective.The challenge of new drug discovery for tuberculosis.Activity of carbapenems combined with clavulanate against murine tuberculosis.Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.Novel inhibitors of Mycobacterium tuberculosis dTDP-6-deoxy-L-lyxo-4-hexulose reductase (RmlD) identified by virtual screening.Current development and future prospects in chemotherapy of tuberculosisCombinations of β-Lactam Antibiotics Currently in Clinical Trials Are Efficacious in a DHP-I-Deficient Mouse Model of Tuberculosis InfectionIn Vitro Activity of β-Lactams in Combination with β-Lactamase Inhibitors against Multidrug-Resistant Mycobacterium tuberculosis Isolates.
P2860
Q24531943-19C16FF2-AB9C-4D45-A434-E189BB0F2691Q27653470-A766A7AD-F158-4DB0-AFA9-7519F8C44881Q27660125-FBE37C22-A86F-4BEC-AAA2-6AA9BE8D85FEQ27666113-F464CFA3-3877-4027-87EA-3E0778E56EE6Q27679915-9DBC2888-FF16-47A8-9E5A-DB06D5C8451AQ27680025-4FFCA06F-4598-4BBC-913F-C90CF92BAA45Q28206091-DDF58649-DA76-4CCC-9675-81799E3316C8Q28217016-8C6039DA-5945-4E6B-B9CA-46A4C3CD5F51Q28379554-0D480B2A-36E2-4770-8FA7-53AACCFE2165Q28486366-778A169F-D261-49AE-B39D-3E9F17D3C87AQ28486458-2A9B13C5-803C-4231-8577-CCF0045556C0Q28486681-CD82A317-13E3-434D-92A0-2F685E513FBAQ28486819-40F58ABC-63D9-4AAB-A6EF-5960152EE488Q28486853-56161C72-E889-4818-878A-D0FAA9336804Q28486891-77DFC80F-E826-4460-9616-988F835DFB66Q28487052-F46709DE-5D5B-4207-9F40-4B29FAA3E63EQ28487054-1E01B92E-4CFD-433D-8104-726E5B0683FDQ28487218-3F662042-F556-4DD5-B785-37DEC26038A5Q28487254-C8DBD86E-CBE3-498B-AD0B-C0315645736FQ28487277-C8007B2B-F802-4208-B2D1-78CA3C547605Q28487411-83F41A78-76CB-41AC-80F1-3AC161CF4A97Q28487414-0F1DEBED-679E-496F-8A1D-C6585E121745Q28487534-BD01476D-499D-42D6-8A5E-1DB58EE28099Q28487606-A5AC80D6-2198-4E07-AC08-0F9E29373C8BQ28501859-FE365D3A-F23D-4679-81F2-92BEF27D931AQ29616208-28E7E054-0AAE-4451-ACE4-854FF276EFE6Q30160015-7C04AC4C-F9AE-4525-AB84-DF95300FFF7CQ33714602-CA30314A-0121-480B-BA2B-80C6B7585195Q34225391-89A0E952-FC82-461E-BF37-21CCDB4D687AQ34229876-7EAC242F-FA30-4FDF-B6CA-EED9B8502DEEQ34300761-D75E5C87-7103-486B-A0AF-821E2AF84D4CQ34368680-7D774D4A-6810-4E68-8490-F2598AE6069EQ34655886-BEE6D6A7-DEFC-43EF-9F64-948B4062F3ECQ34660424-A3922B00-E1CF-4CD7-8184-5475F8332D6DQ35004912-AA2B8B05-3077-44A9-AB2C-EDE34BEF0EC2Q35125890-F5FEB502-AA19-4FDC-A6C1-AF8EEE5365E8Q35570052-31C83ECE-218D-439B-8D41-E5CEED6E0B4EQ35705874-551C597B-67E0-4582-83C1-F2FB5E05A5EDQ35860128-87EFEA8A-57D9-4B26-840C-39AB0D7C9009Q36438910-5674E2B5-4C86-401D-A0DC-0F961AA6914E
P2860
Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?
description
1995 nî lūn-bûn
@nan
1995 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?
@ast
Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?
@en
Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?
@nl
type
label
Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?
@ast
Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?
@en
Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?
@nl
prefLabel
Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?
@ast
Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?
@en
Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?
@nl
P2093
P2860
P356
P1476
Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?
@en
P2093
C Hackbarth
E Rosenberg
H F Chambers
W K Hadley
P2860
P304
P356
10.1128/AAC.39.12.2620
P407
P577
1995-12-01T00:00:00Z